Evaluation
*
*

Thinking about the impact of this session on your patients, please offer an estimate of the:

*
%
*
/month
*
1 (Disagree)2345 (Agree)
Describe Lynch syndrome and identify patients at risk for having Lynch syndrome
Recognize other hereditary colorectal cancer (CRC) syndromes, particularly polyposis conditions
Interpret immunohistochemical staining results for the four mismatch repair proteins and other tumor screening test results for Lynch syndrome
Understand the difference in cancer surveillance for individuals with Lynch syndrome compared to those in the general population
Describe the role of biomarkers (eg, BRAF, KRAS, NRAS) and MSI-H in predicting response to targeted therapies used for the treatment of CRC
*
1 (Low)2345 (High)
Heather Hampel, MS, LGC
Michael Hall, MD, MS
*
*